Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Breztri Aerosphere
Pharma
AZ's Breztri picks up 2nd FDA nod, unlocking asthma market
After smashing the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has passed another crucial milestone.
Fraiser Kansteiner
Apr 28, 2026 10:47am
AstraZeneca adds $136M investment to Chinese inhalants facility
Nov 5, 2025 11:14am
AZ looks to grow Airsupra's reach with new asthma data
May 19, 2025 12:15pm
AZ's Breztri set up for label expansion with 2 asthma trial wins
May 2, 2025 11:30am
AstraZeneca's new TV spot for COPD drug Breztri sets sail
Oct 22, 2024 7:35am
AstraZeneca hit with FDA warning letter over Breztri sales aid
Aug 16, 2023 5:28am